Warburg Pincus & Co.'s Form 4 filing
Sotera Health Co (SHC) · filed Sep 9, 2024
- Accession no.
- 0001999371-24-011715
- Filed
- Sep 9, 2024, 7:13 PM ET
- Trade date
- Sep 6, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $225.4M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Warburg Pincus & Co.CIK 0000929408 | Director, 10% Owner |
| Warburg Pincus Private Equity XI, L.P.CIK 0001540163 | Director, 10% Owner |
| WP XI Partners, L.P.CIK 0001540164 | Director, 10% Owner |
| Warburg Pincus Private Equity XI-B, L.P.CIK 0001540166 | Director, 10% Owner |
| Warburg Pincus XI, L.P.CIK 0001540167 | Director, 10% Owner |
| WP Global LLCCIK 0001540385 | Director, 10% Owner |
| Warburg Pincus XI Partners, L.P.CIK 0001540386 | Director, 10% Owner |
| Warburg Pincus Partners II, L.P.CIK 0001658787 | Director |
| Bull Co-Invest L.P.CIK 0001832693 | Director, 10% Owner |
| Bull Holdco L.P.CIK 0002014247 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 6, 2024 | Common Stock, $0.01 par value per share ("Common Stock") | SSaleDisposed | −15,000,000 | $15.03 | −$225,450,000 | 73,822,952 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Form 1 of 2. Two reports are filed that relate to the same transactions. See Form 2 of 2 for additional reporting entities.